Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 4,888.0 | 2,886.0 | 885.0 | 291.0 |
Revenue growth | 69.4% | 226.1% | 204.1% | |
Cost of goods sold | 2,338.0 | 1,368.0 | 523.0 | 228.0 |
Gross profit | 2,550.0 | 1,518.0 | 362.0 | 63.0 |
Gross margin | 52.2% | 52.6% | 40.9% | 21.6% |
Sales and marketing | 1,619.0 | 957.0 | 594.0 | 135.0 |
Research and development | 430.0 | 321.0 | 107.0 | 51.0 |
General and administrative | 797.0 | 556.0 | 245.0 | 78.0 |
EBITA | -439.0 | -385.0 | -609.0 | -210.0 |
EBITA margin | -9.0% | -13.3% | -68.8% | -72.2% |
Amortization of intangibles | 13.0 | 51.0 | 7.0 | |
EBIT | -452.0 | -436.0 | -616.0 | -210.0 |
EBIT margin | -9.2% | -15.1% | -69.6% | -72.2% |
Pre-tax income | -463.0 | -458.0 | -666.0 | -204.0 |
Income taxes | 5.0 | 3.0 | 1.0 | 0.0 |
Tax rate | | | | 0.0% |
Net income | -468.0 | -461.0 | -668.0 | -207.0 |
Net margin | -9.6% | -16.0% | -75.5% | -71.1% |
|
Diluted EPS | ($1.39) | ($7.39) | ($15.44) | ($4.67) |
Shares outstanding (diluted) | 336.8 | 62.4 | 43.3 | 44.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|